XIWU MIXTURE COMBINED WITH MARVELON IN THE TREATMENT OF PERIMENOPA-USAL DYSFUNCTIONAL UTERINE BLEEDING / 现代医院

Objective To observe the clinical effect of Siwu mixture combined with Marvelon in the treat-ment of perimenopausal dysfunctional uterine bleeding.Methods 148patients with perimenopausal dysfunctional u-terine bleeding were randomly divided into observation group and control group with 74 cases in each group the control group was treated by Marvelon alone, the observation group was treated with Siwu mixture on the basis of the control group.Results After treatment, the established indexes in the observation group were significantly better than the control group (p <0.05); the clinical total effective rate of the observation group was 93.2%, the control group was 73%, there was statistical significance in the observation group compared with the control group (X2 =9.512,p =0.004).Conclusion The safety and effectiveness of Siwu mixture combined with Marvelon in the treatment of peri-menopausal functional uterine bleeding is extremely satisfactory and is worth further promotion.

Clinical Observation of Mifepristone Cycle Therapy in the Treatment of Perimenopausal Dysfunctional Uter-ine Bleeding / 中国药房

OBJECTIVE:To observe the efficacy and safety of mifepristone cycle therapy in the treatment of perimenopausal dysfunctional uterine bleeding. METHODS:Totally 116 patients with perimenopausal dysfunctional uterine bleeding were randomly divided into control group and observation group. Control group was given Mifepristone tablet 10 mg from 3 d after diagnostic cu-rettage on an empty stomach for continuous 90 d,once a day. Observation group was given Mifepristone tablet 10 mg from 3 d af-ter diagnostic curettage on an empty stomach,once a day,and it was stopped after continuous 5 d. Then it continued 5 d from the first day of menstruation,and lasted 3 menstrual cycles. The clinic data was observed,including clinical efficacy,estradiol(E2),fol-licle-stimulating hormone (FSH),luteinizing hormone (LH),progesterone (P),hemoglobin (Hb),endometrial thickness,men-strual conditions and recurrence in 2 groups before and after treatment were observed,and the incidence of adverse reactions were recorded. RESULTS:After treatment,E2,FSH,LH and P in 2 groups were significantly lower than before,and observation group was lower than control group,the differences were statistically significant(P0.05). Total effective rate in observation group significantly higher than control group,normal proportion of menstruation were significantly better than control group,the differences were statistically sig-nificant(P0.05). CONCLUSIONS:Mifepristone cycle therapy has significant efficacy in the treatment of perimenopausal dysfunctional uterine bleeding,can significantly improve the hormone level and the establishment of normal menstrual cycle and re-duce endometrial thickness,with good safety.

Experience of CHEN Ying-yi in treating perimenopausal women’s dysfunctional uterine bleeding / 中华中医药杂志

This article introduces the experience of CHEN Ying-yi, chief physician and one of the teacher of the fourth group of inheriting academic experience of veteran TCM experts of China, in treating perimenopausal women’s dysfunctional uterine bleeding. Chen holds that the basic pathogenesis of perimenopausal dysfunctional uterine bleeding is kidney deficiency with fever or stagnation. Treatment should focus on replenishing kidney and using the traditional Chinese drug by stages. The methods of stopping bleeding, clearing origin and reinstating the status quo are used flexibly. In clinic, it should grasp the key points of syndrome differentiation, and modify the therapy in accordance with the symptoms. Validated by clinical application, Chen’s experience has satisfactory curative effect and reference values for the treatment of perimenopausal women’s dysfunctional uterine bleeding.